1402345-34-9

Upstream product

• 1402345-30-5 4-chloro-N-methoxy-N-methyl-2-phenylamino-benzamide 
• 1402345-31-6 1-(4-chloro-2-phenylamino-phenyl)propan-1-one 
• 1402345-32-7 N-(5-chloro-2-propionyl-phenyl)-N-phenyl-oxalamic acid methyl ester 
• 1402345-33-8 7-chloro-3-methyl-4-oxo-1-phenyl-1,4-dihydro-quinoline-2-carboxylic acid methyl ester 
• 62-53-3 aniline 
• 19218-88-3 N-phenyl-4-chloroanthranilic acid 
• 936-08-3 2-bromo-4-chlorobenzoic acid 

Downstream Products

• 1402345-35-0 7-chloro-3-(4-methoxycarbonyl-2-oxo-2H-pyridin-1-ylmethyl)-4-oxo-1-phenyl-1,4-dihydro-quinoline-2-carboxylic acid methyl ester 
• 1418025-62-3 7-chloro-3-(isoquinolin-1-ylaminomethyl)-4-oxo-1-phenyl-1,4-dihydro-quinoline-2-carboxylic acid methyl ester 
• 1418025-63-4 7-chloro-4-oxo-1-phenyl-3-(quinazolin-4-ylaminomethyl)-1,4-dihydro-quinoline-2-carboxylic acid methyl ester 
• 1418024-63-1 7-chloro-3-[(4-methanesulfonyl-benzoylamino)methyl]-4-oxo-1-phenyl-1,4-dihydro-quinoline-2-carboxylic acid methyl ester 
• 1418024-86-8 7-chloro-3-[(4-chloro-benzoylamino)methyl]-4-oxo-1-phenyl-1,4-dihydro-quinoline-2-carboxylic acid methyl ester 
• 1418025-64-5 7-chloro-3-{[(morpholine-4-carbonyl)amino]methyl}-4-oxo-1-phenyl-1,4-dihydro-quinoline-2-carboxylic acid methyl ester 
• 1418025-65-6 7-chloro-4-oxo-3-(phenoxycarbonylamino-methyl)-1-phenyl-1,4-dihydro-quinoline-2-carboxylic acid methyl ester 
• 1418025-66-7 7-chloro-3-{[(4-methanesulfonyl-benzoyl)methyl-amino]methyl}-4-oxo-1-phenyl-1,4-dihydro-quinoline-2-carboxylic acid methyl ester 
• 1418025-99-6 3-azidomethyl-7-chloro-4-oxo-1-phenyl-1,4-dihydro-quinoline-2-carboxylic acid methyl ester 
• 1418026-00-2 3-aminomethyl-7-chloro-4-oxo-1-phenyl-1,4-dihydro-quinoline-2-carboxylic acid methyl ester hydrochloride 

Relevant academic research and scientific papers

AMINOMETHYL QUINOLONE COMPOUNDS

The invention relates to JNK inhibitors and corresponding methods, formulations, and compositions for inhibiting JNK and treating JNK-mediated disorders. The application discloses JNK inhibitors, as described below in Formula (I): wherein the variables ar

ADAMANTYL COMPOUNDS

The invention relates to JNK inhibitors and corresponding methods, formulations, and compositions for inhibiting JNK and treating JNK-mediated disorders. The application discloses JNK inhibitors, as described below in Formula I: wherein the variables are